Leqvio (inclisiran)

pCPA File Number: 21784

Negotiation Status:

Under consideration for negotiation

Indication(s):

Primary hypercholesterolemia (non-familial and heterozygous familial)

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

SR0681-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable